Insulet Corporation (PODD)Healthcare | Medical Devices | Acton, United States | NasdaqGS
145.13 USD
+1.72
(1.199%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 145.31 +0.18 (0.121%) ⇧ (Aug. 28, 2026, 7:38 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:34 a.m. EDT
Insulet demonstrates exceptional long-term business quality with 23.5 percent revenue growth and a 26 percent return on equity, supported by a nine-year cumulative gain of over 650 percent. However, the stock is currently trading near its 52-week low and below its 50-day and 200-day moving averages, indicating negative short-term momentum. Recent headlines regarding fraud litigation introduce significant legal risk that complicates the investment thesis. While the underlying medical device franchise is robust, the combination of negative technicals and legal overhang warrants caution for near-term entries. Options activity confirms this tension, with heavy put volume at current price levels signaling a desire for downside protection. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.066500 |
| AutoETS | 0.078267 |
| AutoTheta | 0.186458 |
| AutoARIMA | 0.261723 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 6.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.268 |
| Excess Kurtosis | -0.31 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 66.685 |
| Revenue per Share | 43.618 |
| Market Cap | 10,065,375,232 |
| Trailing P/E | 26.88 |
| Forward P/E | 18.82 |
| Beta | 1.10 |
| Profit Margins | 12.29% |
| Website | https://www.insulet.com |
As of Aug. 22, 2026, 4:34 a.m. EDT: Implied volatility is elevated across expirations, indicating uncertainty. Put open interest is concentrated at 130-140 strikes, suggesting significant downside hedging or bearish positioning near current levels. Call open interest peaks at the 200 strike, reflecting speculative upside targets. The mix suggests a range-bound outlook with asymmetric risk management.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.58422244 |
| Address1 | 100 Nagog Park |
| All Time High | 354.88 |
| All Time Low | 2.57 |
| Ask | 145.3 |
| Ask Size | 1 |
| Audit Risk | 1 |
| Average Daily Volume10 Day | 1,404,430 |
| Average Daily Volume3 Month | 1,560,811 |
| Average Volume | 1,560,811 |
| Average Volume10Days | 1,404,430 |
| Beta | 1.095 |
| Bid | 144.8 |
| Bid Size | 1 |
| Board Risk | 2 |
| Book Value | 20.507 |
| City | Acton |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 145.13 |
| Current Ratio | 2.485 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 146.67 |
| Day Low | 143.805 |
| Debt To Equity | 66.685 |
| Display Name | Insulet |
| Earnings Call Timestamp End | 1,785,931,200 |
| Earnings Call Timestamp Start | 1,785,931,200 |
| Earnings Growth | 3.286 |
| Earnings Quarterly Growth | 3.222 |
| Earnings Timestamp | 1,785,933,000 |
| Earnings Timestamp End | 1,793,881,800 |
| Earnings Timestamp Start | 1,793,881,800 |
| Ebitda | 614,899,968 |
| Ebitda Margins | 0.20138 |
| Enterprise To Ebitda | 17.042 |
| Enterprise To Revenue | 3.432 |
| Enterprise Value | 10,478,874,624 |
| Eps Current Year | 6.5029 |
| Eps Forward | 7.71086 |
| Eps Trailing Twelve Months | 5.4 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 154.0522 |
| Fifty Day Average Change | -8.922195 |
| Fifty Day Average Change Percent | -0.0579167 |
| Fifty Two Week Change Percent | -58.422245 |
| Fifty Two Week High | 354.88 |
| Fifty Two Week High Change | -209.75 |
| Fifty Two Week High Change Percent | -0.59104484 |
| Fifty Two Week Low | 126.4 |
| Fifty Two Week Low Change | 18.730003 |
| Fifty Two Week Low Change Percent | 0.14818041 |
| Fifty Two Week Range | 126.4 - 354.88 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,179,235,800,000 |
| Float Shares | 69,063,605 |
| Forward Eps | 7.71086 |
| Forward P E | 18.821508 |
| Free Cashflow | 236,900,000 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 5,400 |
| Fullday Change | 1.72 |
| Fullday Change Percent | 1.19936 |
| Fullday Price | 145.306 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.71075 |
| Gross Profits | 2,170,200,064 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00329 |
| Held Percent Institutions | 1.07011 |
| Implied Shares Outstanding | 69,354,199 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://investor.insulet.com/index.cfm |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. |
| Long Name | Insulet Corporation |
| Market | us_market |
| Market Cap | 10,065,375,232 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_618908 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 375,300,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,946,085,678 |
| Number Of Analyst Opinions | 22 |
| Open | 144.0 |
| Operating Cashflow | 511,200,000 |
| Operating Margins | 0.16178 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.44 |
| Phone | 978 600 7000 |
| Post Market Change | 0.17599487 |
| Post Market Change Percent | 0.12126705 |
| Post Market Price | 145.306 |
| Post Market Time | 1,787,960,301 |
| Previous Close | 143.41 |
| Price Eps Current Year | 22.317736 |
| Price Hint | 2 |
| Price To Book | 7.077096 |
| Price To Sales Trailing12 Months | 3.2964482 |
| Profit Margins | 0.12291 |
| Quick Ratio | 1.51 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 1.72 |
| Regular Market Change Percent | 1.19936 |
| Regular Market Day High | 146.67 |
| Regular Market Day Low | 143.805 |
| Regular Market Day Range | 143.805 - 146.67 |
| Regular Market Open | 144.0 |
| Regular Market Previous Close | 143.41 |
| Regular Market Price | 145.13 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 1,043,227 |
| Return On Assets | 0.09715 |
| Return On Equity | 0.26016 |
| Revenue Growth | 0.235 |
| Revenue Per Share | 43.618 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 10 |
| Shares Outstanding | 69,354,199 |
| Shares Percent Shares Out | 0.0533 |
| Shares Short | 3,696,321 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 4,645,027 |
| Short Name | Insulet Corporation |
| Short Percent Of Float | 0.0602 |
| Short Ratio | 2.2 |
| Source Interval | 15 |
| State | MA |
| Symbol | PODD |
| Target High Price | 275.0 |
| Target Low Price | 144.0 |
| Target Mean Price | 171.90909 |
| Target Median Price | 167.5 |
| Total Cash | 534,900,000 |
| Total Cash Per Share | 7.713 |
| Total Debt | 948,400,000 |
| Total Revenue | 3,053,400,064 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 5.4 |
| Trailing P E | 26.875927 |
| Trailing Peg Ratio | 1.441 |
| Triggerable | 1 |
| Two Hundred Day Average | 215.6438 |
| Two Hundred Day Average Change | -70.513794 |
| Two Hundred Day Average Change Percent | -0.32699198 |
| Type Disp | Equity |
| Volume | 1,043,227 |
| Website | https://www.insulet.com |
| Zip | 1,720 |